 | • レポートコード：B-GIR08C3461 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ロラチニブの世界市場について調べ、まとめました。種類別セグメントは、25mg、100mg等、用途別セグメントは、NSCLC扁平上皮癌、NSCLC腺癌、NSCLC大細胞癌等に区分しました。ロラチニブの世界市場概観、企業動向、企業別ロラチニブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ロラチニブの市場概観 ・ロラチニブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ロラチニブの企業別販売動向、市場シェア、市場集中度、競争動向 ・ロラチニブの世界市場規模 ・ロラチニブの北米市場分析（アメリカ、カナダ、メキシコ等） ・ロラチニブのアメリカ市場規模推移 ・ロラチニブのカナダ市場規模推移 ・ロラチニブのメキシコ市場規模推移 ・ロラチニブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ロラチニブのドイツ市場規模推移 ・ロラチニブのイギリス市場規模推移 ・ロラチニブのロシア市場規模推移 ・ロラチニブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ロラチニブの日本市場規模推移 ・ロラチニブの中国市場規模推移 ・ロラチニブの韓国市場規模推移 ・ロラチニブのインド市場規模推移 ・ロラチニブの東南アジア市場規模推移 ・ロラチニブの南米市場分析（ブラジル、アルゼンチン等） ・ロラチニブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ロラチニブの種類別分析/販売量、売上、市場シェア（25mg、100mg） ・ロラチニブの用途別分析/市場規模（NSCLC扁平上皮癌、NSCLC腺癌、NSCLC大細胞癌） ・ロラチニブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ロラチニブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Lorlatinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Lorlatinib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tables 25mg
Tables 100mg
Market Segment by Applications, can be divided into
Squamous Cell Carcinoma of NSCLC
Adenocarcinoma of NSCLC
Large Cell Carcinoma of NSCLC
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lorlatinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lorlatinib, with price, sales, revenue and global market share of Lorlatinib in 2017 and 2018.
Chapter 3, the Lorlatinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lorlatinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Lorlatinib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Lorlatinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Lorlatinib Introduction
1.2 Market Analysis by Type
1.2.1 Tables 25mg
1.2.2 Tables 100mg
1.3 Market Analysis by Applications
1.3.1 Squamous Cell Carcinoma of NSCLC
1.3.2 Adenocarcinoma of NSCLC
1.3.3 Large Cell Carcinoma of NSCLC
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Lorlatinib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Lorlatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Lorlatinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Lorlatinib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Lorlatinib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Lorlatinib Manufacturer Market Share in 2018
3.3.2 Top 6 Lorlatinib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Lorlatinib Market Analysis by Regions
4.1 Global Lorlatinib Sales, Revenue and Market Share by Regions
4.1.1 Global Lorlatinib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Lorlatinib Revenue and Market Share by Regions (2014-2019)
4.2 North America Lorlatinib Sales and Growth Rate (2014-2019)
4.3 Europe Lorlatinib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Lorlatinib Sales and Growth Rate (2014-2019)
4.5 South America Lorlatinib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Lorlatinib Sales and Growth Rate (2014-2019)
5 North America Lorlatinib by Country
5.1 North America Lorlatinib Sales, Revenue and Market Share by Country
5.1.1 North America Lorlatinib Sales and Market Share by Country (2014-2019)
5.1.2 North America Lorlatinib Revenue and Market Share by Country (2014-2019)
5.2 United States Lorlatinib Sales and Growth Rate (2014-2019)
5.3 Canada Lorlatinib Sales and Growth Rate (2014-2019)
5.4 Mexico Lorlatinib Sales and Growth Rate (2014-2019)
6 Europe Lorlatinib by Country
6.1 Europe Lorlatinib Sales, Revenue and Market Share by Country
6.1.1 Europe Lorlatinib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Lorlatinib Revenue and Market Share by Country (2014-2019)
6.2 Germany Lorlatinib Sales and Growth Rate (2014-2019)
6.3 UK Lorlatinib Sales and Growth Rate (2014-2019)
6.4 France Lorlatinib Sales and Growth Rate (2014-2019)
6.5 Russia Lorlatinib Sales and Growth Rate (2014-2019)
6.6 Italy Lorlatinib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Lorlatinib by Country
7.1 Asia-Pacific Lorlatinib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Lorlatinib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Lorlatinib Revenue and Market Share by Country (2014-2019)
7.2 China Lorlatinib Sales and Growth Rate (2014-2019)
7.3 Japan Lorlatinib Sales and Growth Rate (2014-2019)
7.4 Korea Lorlatinib Sales and Growth Rate (2014-2019)
7.5 India Lorlatinib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Lorlatinib Sales and Growth Rate (2014-2019)
8 South America Lorlatinib by Country
8.1 South America Lorlatinib Sales, Revenue and Market Share by Country
8.1.1 South America Lorlatinib Sales and Market Share by Country (2014-2019)
8.1.2 South America Lorlatinib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Lorlatinib Sales and Growth Rate (2014-2019)
8.3 Argentina Lorlatinib Sales and Growth Rate (2014-2019)
8.4 Colombia Lorlatinib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Lorlatinib by Countries
9.1 Middle East and Africa Lorlatinib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Lorlatinib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Lorlatinib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Lorlatinib Sales and Growth Rate (2014-2019)
9.3 Turkey Lorlatinib Sales and Growth Rate (2014-2019)
9.4 Egypt Lorlatinib Sales and Growth Rate (2014-2019)
9.5 Nigeria Lorlatinib Sales and Growth Rate (2014-2019)
9.6 South Africa Lorlatinib Sales and Growth Rate (2014-2019)
10 Global Lorlatinib Market Segment by Type
10.1 Global Lorlatinib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Lorlatinib Sales and Market Share by Type (2014-2019)
10.1.2 Global Lorlatinib Revenue and Market Share by Type (2014-2019)
10.2 Tables 25mg Sales Growth and Price
10.2.1 Global Tables 25mg Sales Growth (2014-2019)
10.2.2 Global Tables 25mg Price (2014-2019)
10.3 Tables 100mg Sales Growth and Price
10.3.1 Global Tables 100mg Sales Growth (2014-2019)
10.3.2 Global Tables 100mg Price (2014-2019)
11 Global Lorlatinib Market Segment by Application
11.1 Global Lorlatinib Sales Market Share by Application (2014-2019)
11.2 Squamous Cell Carcinoma of NSCLC Sales Growth (2014-2019)
11.3 Adenocarcinoma of NSCLC Sales Growth (2014-2019)
11.4 Large Cell Carcinoma of NSCLC Sales Growth (2014-2019)
12 Lorlatinib Market Forecast (2019-2024)
12.1 Global Lorlatinib Sales, Revenue and Growth Rate (2019-2024)
12.2 Lorlatinib Market Forecast by Regions (2019-2024)
12.2.1 North America Lorlatinib Market Forecast (2019-2024)
12.2.2 Europe Lorlatinib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Lorlatinib Market Forecast (2019-2024)
12.2.4 South America Lorlatinib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Lorlatinib Market Forecast (2019-2024)
12.3 Lorlatinib Market Forecast by Type (2019-2024)
12.3.1 Global Lorlatinib Sales Forecast by Type (2019-2024)
12.3.2 Global Lorlatinib Market Share Forecast by Type (2019-2024)
12.4 Lorlatinib Market Forecast by Application (2019-2024)
12.4.1 Global Lorlatinib Sales Forecast by Application (2019-2024)
12.4.2 Global Lorlatinib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Lorlatinib Picture
Table Product Specifications of Lorlatinib
Figure Global Sales Market Share of Lorlatinib by Types in 2018
Table Lorlatinib Types for Major Manufacturers
Figure Tables 25mg Picture
Figure Tables 100mg Picture
Figure Lorlatinib Sales Market Share by Applications in 2018
Figure Squamous Cell Carcinoma of NSCLC Picture
Figure Adenocarcinoma of NSCLC Picture
Figure Large Cell Carcinoma of NSCLC Picture
Figure United States Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure France Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure China Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure India Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Lorlatinib Revenue (Value) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Lorlatinib Type and Applications
Table Pfizer Lorlatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Lorlatinib Sales by Manufacturer (2017-2018)
Figure Global Lorlatinib Sales Market Share by Manufacturer in 2017
Figure Global Lorlatinib Sales Market Share by Manufacturer in 2018
Table Global Lorlatinib Revenue by Manufacturer (2017-2018)
Figure Global Lorlatinib Revenue Market Share by Manufacturer in 2017
Figure Global Lorlatinib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Lorlatinib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Lorlatinib Manufacturer (Revenue) Market Share in 2018
Figure Global Lorlatinib Sales and Growth Rate (2014-2019)
Figure Global Lorlatinib Revenue and Growth Rate (2014-2019)
Table Global Lorlatinib Sales by Regions (2014-2019)
Table Global Lorlatinib Sales Market Share by Regions (2014-2019)
Table Global Lorlatinib Revenue by Regions (2014-2019)
Figure Global Lorlatinib Revenue Market Share by Regions (2014-2019)
Figure Global Lorlatinib Revenue Market Share by Regions in 2018
Figure North America Lorlatinib Sales and Growth Rate (2014-2019)
Figure Europe Lorlatinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Lorlatinib Sales and Growth Rate (2014-2019)
Figure South America Lorlatinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Lorlatinib Sales and Growth Rate (2014-2019)
Figure North America Lorlatinib Revenue and Growth Rate (2014-2019)
Table North America Lorlatinib Sales by Countries (2014-2019)
Table North America Lorlatinib Sales Market Share by Countries (2014-2019)
Figure North America Lorlatinib Sales Market Share by Countries (2014-2019)
Figure North America Lorlatinib Sales Market Share by Countries in 2018
Table North America Lorlatinib Revenue by Countries (2014-2019)
Table North America Lorlatinib Revenue Market Share by Countries (2014-2019)
Figure North America Lorlatinib Revenue Market Share by Countries (2014-2019)
Figure North America Lorlatinib Revenue Market Share by Countries in 2018
Figure United States Lorlatinib Sales and Growth Rate (2014-2019)
Figure Canada Lorlatinib Sales and Growth Rate (2014-2019)
Figure Mexico Lorlatinib Sales and Growth Rate (2014-2019)
Figure Europe Lorlatinib Revenue and Growth Rate (2014-2019)
Table Europe Lorlatinib Sales by Countries (2014-2019)
Table Europe Lorlatinib Sales Market Share by Countries (2014-2019)
Table Europe Lorlatinib Revenue by Countries (2014-2019)
Figure Europe Lorlatinib Revenue Market Share by Countries (2014-2019)
Figure Europe Lorlatinib Revenue Market Share by Countries in 2018
Figure Germany Lorlatinib Sales and Growth Rate (2014-2019)
Figure UK Lorlatinib Sales and Growth Rate (2014-2019)
Figure France Lorlatinib Sales and Growth Rate (2014-2019)
Figure Russia Lorlatinib Sales and Growth Rate (2014-2019)
Figure Italy Lorlatinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Lorlatinib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Lorlatinib Sales by Countries (2014-2019)
Table Asia-Pacific Lorlatinib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Lorlatinib Sales Market Share by Countries 2018
Table Asia-Pacific Lorlatinib Revenue by Countries (2014-2019)
Figure Asia-Pacific Lorlatinib Revenue Market Share by Countries 2018
Figure China Lorlatinib Sales and Growth Rate (2014-2019)
Figure Japan Lorlatinib Sales and Growth Rate (2014-2019)
Figure Korea Lorlatinib Sales and Growth Rate (2014-2019)
Figure India Lorlatinib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Lorlatinib Sales and Growth Rate (2014-2019)
Figure South America Lorlatinib Revenue and Growth Rate (2014-2019)
Table South America Lorlatinib Sales by Countries (2014-2019)
Table South America Lorlatinib Sales Market Share by Countries (2014-2019)
Figure South America Lorlatinib Sales Market Share by Countries in 2018
Table South America Lorlatinib Revenue by Countries (2014-2019)
Table South America Lorlatinib Revenue Market Share by Countries (2014-2019)
Figure South America Lorlatinib Revenue Market Share by Countries in 2018
Figure Brazil Lorlatinib Sales and Growth Rate (2014-2019)
Figure Argentina Lorlatinib Sales and Growth Rate (2014-2019)
Figure Colombia Lorlatinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Lorlatinib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Lorlatinib Sales by Countries (2014-2019)
Table Middle East and Africa Lorlatinib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Lorlatinib Sales Market Share by Countries in 2018
Table Middle East and Africa Lorlatinib Revenue by Countries (2014-2019)
Table Middle East and Africa Lorlatinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Lorlatinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Lorlatinib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Lorlatinib Sales and Growth Rate (2014-2019)
Figure UAE Lorlatinib Sales and Growth Rate (2014-2019)
Figure Egypt Lorlatinib Sales and Growth Rate (2014-2019)
Figure Nigeria Lorlatinib Sales and Growth Rate (2014-2019)
Figure South Africa Lorlatinib Sales and Growth Rate (2014-2019)
Table Global Lorlatinib Sales by Type (2014-2019)
Table Global Lorlatinib Sales Share by Type (2014-2019)
Table Global Lorlatinib Revenue by Type (2014-2019)
Table Global Lorlatinib Revenue Share by Type (2014-2019)
Figure Global Tables 25mg Sales Growth (2014-2019)
Figure Global Tables 25mg Price (2014-2019)
Figure Global Tables 100mg Sales Growth (2014-2019)
Figure Global Tables 100mg Price (2014-2019)
Table Global Lorlatinib Sales by Application (2014-2019)
Table Global Lorlatinib Sales Share by Application (2014-2019)
Figure Global Adenocarcinoma of NSCLC Sales Growth (2014-2019)
Figure Global Large Cell Carcinoma of NSCLC Sales Growth (2014-2019)
Figure Global Lorlatinib Sales, Revenue and Growth Rate (2019-2024)
Table Global Lorlatinib Sales Forecast by Regions (2019-2024)
Table Global Lorlatinib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Lorlatinib Market Forecast (2019-2024)
Figure Europe Sales Lorlatinib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Lorlatinib Market Forecast (2019-2024)
Figure South America Sales Lorlatinib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Lorlatinib Market Forecast (2019-2024)
Table Global Lorlatinib Sales Forecast by Type (2019-2024)
Table Global Lorlatinib Market Share Forecast by Type (2019-2024)
Table Global Lorlatinib Sales Forecast by Application (2019-2024)
Table Global Lorlatinib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
NSCLC用標的薬物MEK阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug MEK Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…- NSCLC用標的薬剤VEGFR2阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug VEGFR2 Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, espe…
- NSCLC用標的薬剤ROS1阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug ROS1 Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especi…
- NSCLC用標的薬BRAF阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug BRAF Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especi…
- NSCLC用標的薬物ALK阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug ALK Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…